Journal of Research in Medical Sciences (Jan 2012)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis

  • Francesca Scicchitano,
  • Chiara Giofrè,
  • Caterina Palleria,
  • Carmela Mazzitello,
  • Miriam Ciriaco,
  • Luca Gallelli,
  • Laura Paletta,
  • Giuseppina Marrazzo,
  • Salvatore De Fazio,
  • Michele Menniti,
  • Rubens Curia,
  • Concetta Arena,
  • Serafina Chimirri,
  • Marinella Patanè,
  • Stefania Esposito,
  • Felisa Cilurzo,
  • Orietta Staltari,
  • Emilio Russo,
  • Giovambattista De Sarro

Journal volume & issue
Vol. 17, no. 9
pp. 872 – 875

Abstract

Read online

Background : Pharmacovigilance assesses the safety profile of drugs. Its main aim is the increase of spontaneous reporting of adverse drug reactions (ADRs). The Italian Drug Agency (AIFA; Agenzia Italiana del Farmaco) is financing several projects to the aim of increasing reporting, and in Calabria a Pharmacovigilance Information Centre has been created. Materials and Methods: We analyzed the AIFA database relatively to Calabria in the year 2011 and we have analyzed ADRs using descriptive statistics. We have also collected a questionnaire-based interview in order to describe the background knowledge in the field. Results : Regarding the number of AIFA reported ADRs from Calabria, a 38% increase (138 vs. 100) in comparison to 2010 was evidenced. Hospital Doctors represent the main source of signaling (71.7 %). Ketoprofene and the combination amoxicillin/clavulanic acid represent the most frequently reported drugs causing ADRs. Our questionnaires indicated that despite the health professionals have met at least once an ADR only a small percentage of them was reported to the authorities (37%). There is a very good knowledge of the ADR concept and reporting system (90% of interviewed distinguish an ADR and knows how to report it), and there is a strong interest in participating to training courses in the field (95% are interested). Conclusions : Despite Calabria has had a positive increase in the number of reported ADRs, the total number is very low and the pharmacovigilance culture is far from being achieved in this region.

Keywords